Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Damp-cmumep
2. N-(2,6-bis(isopropyl)phenyl)-n'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea
1. 133825-80-6
2. Nevanimibe [usan]
3. Pd-132301
4. Atr-101 Free Base
5. 1-(2,6-diisopropylphenyl)-3-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea
6. Chembl46423
7. Pd 132301
8. Vk9os8r205
9. Nevanimibe (usan)
10. 1-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]-3-[2,6-di(propan-2-yl)phenyl]urea
11. Damp-cmumep
12. Chembl542103
13. N-(2,6-bis(isopropyl)phenyl)-n/'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea
14. Rov
15. Nevanimibe [inn]
16. Unii-vk9os8r205
17. Schembl1119314
18. Dtxsid10928286
19. Bdbm50041735
20. Akos037648690
21. Sb17169
22. Bs-15209
23. Hy-100399
24. Cs-0018785
25. D11300
26. D81212
27. Q27291867
28. N-({1-[4-(dimethylamino)phenyl]cyclopentyl}methyl)-n'-[2,6-di(propan-2-yl)phenyl]urea
29. N-(2,6-bis(1-methylethyl)phenyl)-n'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea
30. 1-(2,6-diisopropyl-phenyl)-3-[1-(4-dimethylamino-phenyl)-cyclopentylmethyl]-urea; Hydrochloride
31. N'-({1-[4-(dimethylamino)phenyl]cyclopentyl}methyl)-n-[2,6-di(propan-2-yl)phenyl]carbamimidic Acid
32. N-(2,6-bis(propan-2-yl)phenyl)-n'-((1-(4-(dimethylamino)phenyl) Cyclopentyl)methyl)urea
33. Urea, N-(2,6-bis(1-methylethyl)phenyl)-n'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)-
34. Urea, N-(2,6-bis(1-methylethyl)phenyl)-n'-((1-(4-dimethylamino)phenyl)cyclopentyl)methyl)-
| Molecular Weight | 421.6 g/mol |
|---|---|
| Molecular Formula | C27H39N3O |
| XLogP3 | 6.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 7 |
| Exact Mass | 421.309312876 g/mol |
| Monoisotopic Mass | 421.309312876 g/mol |
| Topological Polar Surface Area | 44.4 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 543 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
12
PharmaCompass offers a list of Nevanimibe API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nevanimibe manufacturer or Nevanimibe supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nevanimibe manufacturer or Nevanimibe supplier.
PharmaCompass also assists you with knowing the Nevanimibe API Price utilized in the formulation of products. Nevanimibe API Price is not always fixed or binding as the Nevanimibe Price is obtained through a variety of data sources. The Nevanimibe Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Nevanimibe manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nevanimibe, including repackagers and relabelers. The FDA regulates Nevanimibe manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nevanimibe API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nevanimibe supplier is an individual or a company that provides Nevanimibe active pharmaceutical ingredient (API) or Nevanimibe finished formulations upon request. The Nevanimibe suppliers may include Nevanimibe API manufacturers, exporters, distributors and traders.
Nevanimibe Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nevanimibe GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nevanimibe GMP manufacturer or Nevanimibe GMP API supplier for your needs.
A Nevanimibe CoA (Certificate of Analysis) is a formal document that attests to Nevanimibe's compliance with Nevanimibe specifications and serves as a tool for batch-level quality control.
Nevanimibe CoA mostly includes findings from lab analyses of a specific batch. For each Nevanimibe CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nevanimibe may be tested according to a variety of international standards, such as European Pharmacopoeia (Nevanimibe EP), Nevanimibe JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nevanimibe USP).
